BIOS Capital Management as of March 31, 2025
Portfolio Holdings for BIOS Capital Management
BIOS Capital Management holds 6 positions in its portfolio as reported in the March 2025 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Actuate Therapeutics (ACTU) | 84.6 | $67M | 9.9M | 6.77 | |
| Lantern Pharma (LTRN) | 5.4 | $4.3M | 1.2M | 3.54 | |
| Rein Therapeutics Com New (RNTX) | 3.8 | $3.0M | 1.7M | 1.77 | |
| Cognition Therapeutics (CGTX) | 3.2 | $2.5M | 6.0M | 0.42 | |
| In8bio | 1.8 | $1.4M | 8.6M | 0.17 | |
| Ocuphire Pharma (IRD) | 1.2 | $977k | 995k | 0.98 |
